Squamous cell anal carcinoma (SCAC) is a very rare disease, with few approved treatments in the advanced setting. Little benefit has been achieved with currently approved treatments in terms of ...

Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...

Carpal tunnel syndrome is the most common nerve entrapment syndrome in the upper limb, affecting 3–5% of the adult population.1 Depending on local routines and habits, different specialties are ...

Despite being declared a Public Health Emergency of International Concern 10 months ago, the mpox outbreak is not over. And in places like Sierra Leone, it is spiralling. Paul Adepoju reports.

Global migration is an inescapable reality. Whether by choice or by force, 1 billion people (one in eight of the total world population) are on the move today, driven by economic, political, ...

Cancer is the third leading cause of death in Kenya, after infectious and cardiovascular diseases.1 According to the National Institutes of Health, 50% of all cancer patients receive radiotherapy as ...

Management of older adults with type 2 diabetes and chronic kidney disease is complex. These individuals often have multiple comorbidities, take several medications, and are at increased risk of ...

US Health and Human Services Secretary Robert F Kennedy Jr announced that the CDC, for which he has overall control, would be withdrawing its recommendation for routine COVID-19 vaccination for ...

The Lancet Oncology’s Series on Cancer control in the Middle East comprises five papers from regional experts who discuss the current outlook for cancer in the Middle East and future developments ...

Samuel S Myers, Professor at the Johns Hopkins Bloomberg School of Public Health and the Director of the Johns Hopkins ...

Papua New Guinea's community volunteers provide essential services and health promotion, but the absence of financial support ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...